This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Tocris Bioscience
product type :
chemical
product name :
Aminopurvalanol A
catalog :
2072/10
quantity :
10 mg (also 50 mg)
price :
252 USD
citations: 1
Reference |
---|
Teo R, Möhrlen F, Plickert G, Müller W, Frank U. An evolutionary conserved role of Wnt signaling in stem cell fate decision. Dev Biol. 2006;289:91-9 pubmed
|
product information
brand :
Tocris
master code :
2072
SKU :
2072/10
product name :
Aminopurvalanol A
unit size :
10 mg (also 50 mg)
seo description :
Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5
target :
Cyclin-dependent Kinase Inhibitors
category :
Small Molecules
purity :
98%
observed molecular weight :
403.91
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
Aminopurvalanol A is a cyclin-dependent kinase (cdk) inhibitor (reported IC50 values are 20 - 35 nM for cdk1, cdk2 and cdk5). Also inhibits ERK1 (IC50 = 12.0 M) and ERK2 (IC50 = 3.1 M) and is 3000-fold selective over a range of other protein kinases (IC50 100 M). Arrests cell cycle at G2/M boundary (IC50 = 1.25 M), and induces apoptosis at concentrations 10 M. Cell permeable.
top caption :
Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5
extended description :
Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5
chemical name text :
(2R)-2-[[6-[(3-Amino-5-chlorophenyl)amino]-9-(1-methylethyl)-9H-purin-2-yl]amino]-3-methyl-1-butanol
formula :
C19H26ClN7O
formula text :
C19H26ClN7O
cas num :
220792-57-4
USD :
252 USD
product details :
Selective cdk inhibitor; potently inhibits cdk1, cdk2 and cdk5
alt names :
NG 97
storage :
Store at +4░C
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
questions and comments